Specifically, the results demonstrated that AME improved insulin metabolism, lipid metabolism, and autophagy pathway which are related with non-alcoholic fatty liver disease (NAFLD) risk in type 2 diabetes mellitus (T2DM). The gene discussed is INS; the disease is type 2 diabetes mellitus.